The Use of New Mass Spectrometry Methods to Visualize Lipids

The Use of New Mass Spectrometry Methods to Visualize Lipids ...

Further research into phosphoinositides, which are essential for many biological and pathological processes, has enabled the detection of tiny but significant changes in intracellular phosphoinositide levels. PRMC-MS is now able to entail the development of novel therapies for cancer and other diseases.

In addition, the use of PRMC-MS to assess phosphoinositide signatures at the acyl variant level in tissue and liquid biopsies may reveal biomarkers suitable for a wide variety of clinical applications.

Applications such as the above may be beneficial in the future, particularly when it comes to the creation of a therapeutic agent that identifies a specific pathogenic phosphoinositide acyl variant, and thus opens the way for more precise therapeutic methods and therapies for patients with severe illnesses.

You may also like: